Lysophosphatidylcholine-induced cytotoxicity in osteoblast-like MG-63 cells: Involvement of transient receptor potential vanilloid 2 (TRPV2) channels

References

• Abed E, Labelle D, Martineau C, Loghin A, Moreau R. 2009. Expression of transient receptor potential (TRP) channels in human and murine osteoblast-like cells. Mol Membr Biol 26:146–158.
   Web of Science ®Google Scholar
• Abed E, Moreau R. 2007. Importance of melastatin-like transient receptor potential 7 and cations (magnesium, calcium) in human osteoblast-like cell proliferation. Cell Prolif 40:849–865.
   Google Scholar
• Barengolts EI, Berman M, Kukreja SC, Kouznetsova T, Lin C, Chomka EV. 1998. Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women. Calcif Tissue Int 62:209–213.
   PubMed Web of Science ®Google Scholar
• Brodeur MR, Brissette L, Falstrault L, Luangrath V, Moreau R. 2008a. Scavenger receptor of class B expressed by osteoblastic cells are implicated in the uptake of cholesteryl ester and estradiol from LDL and HDL3. J Bone Miner Res 23:326–337.
   PubMed Web of Science ®Google Scholar
• Brodeur MR, Brissette L, Falstrault L, Ouellet P, Moreau R. 2008b. Influence of oxidized low-density lipoproteins (LDL) on the viability of osteoblastic cells. Free Radic Biol Med 44:506–517.
   Google Scholar
• Brown AJ, Jessup W. 1999. Oxysterols and atherosclerosis. Atherosclerosis 142:1–28.
   PubMed Web of Science ®Google Scholar
• Castelli WP, Doyle JT, Gordon T, Hames CG, Hjortland MC, Hulley SB, et al. 1977. HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation 55:767–772.
   PubMed Web of Science ®Google Scholar
• Chaudhuri P, Colles SM, Bhat M, Van Wagoner DR, Birnbaumer L, Graham LM. 2008. Elucidation of a TRPC6-TRPC5 channel cascade that restricts endothelial cell movement. Mol Biol Cell 19:3203–3211.
   Google Scholar
• Flemming PK, Dedman AM, Xu SZ, Li J, Zeng F, Naylor J, et al. 2006. Sensing of lysophospholipids by TRPC5 calcium channel. J Biol Chem 281:4977–4982.
   Google Scholar
• Fuchs B, Schiller J. 2009. Lysophospholipids: Their generation, physiological role and detection. Are they important disease markers? Mini Rev Med Chem 9:368–378.
   PubMed Web of Science ®Google Scholar
• Hamel P, Abed E, Brissette L, Moreau R. 2008. Characterization of oxidized low density lipoproteins-induced hormesis-like effects in osteoblastic cells. Am J Physiol Cell Physiol 294:C1021–C1033.
   Google Scholar
• Hsieh CC, Yen MH, Liu HW, Lau YT. 2000. Lysophosphatidylcholine induces apoptotic and non-apoptotic death in vascular smooth muscle cells: In comparison with oxidized LDL. Atherosclerosis 151:481–491.
   PubMed Web of Science ®Google Scholar
• Hsu JH, Wu JR, Liou SF, Chen HM, Dai ZK, Chen IJ, et al. 2011. Labedipinedilol-A prevents lysophosphatidylcholine-induced vascular smooth muscle cell death through reducing reactive oxygen species production and anti-apoptosis. Atherosclerosis 217:379–386.
   Google Scholar
• Ingueneau C, Huynh UD, Marcheix B, Athias A, Gambert P, Negre-Salvayre A, et al. 2009. TRPC1 is regulated by caveolin-1 and is involved in oxidized LDL-induced apoptosis of vascular smooth muscle cells. J Cell Mol Med 13:1620–1631.
   PubMed Web of Science ®Google Scholar
• Iwata Y, Katanosaka Y, Arai Y, Komamura K, Miyatake K, Shigekawa M. 2003. A novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor-regulated channel. J Cell Biol 161:957–967.
   PubMed Web of Science ®Google Scholar
• Klein BY, Kerem Z, Rojansky N. 2006. LDL induces Saos2 osteoblasts death via Akt pathways responsive to a neutral sphingomyelinase inhibitor. J Cell Biochem 98:661–671.
   Google Scholar
• Klein BY, Rojansky N, Ben Yehuda A, Abou-Atta I, Abedat S, Friedman G. 2003. Cell death in cultured human Saos2 osteoblasts exposed to low-density lipoprotein. J Cell Biochem 90:42–58.
   Google Scholar
• Labelle D, Jumarie C, Moreau R. 2007. Capacitative calcium entry and proliferation of human osteoblast-like MG-63 cells. Cell Prolif 40:866–884.
   Google Scholar
• Lin P, Ye RD. 2003. The lysophospholipid receptor G2A activates a specific combination of G proteins and promotes apoptosis. J Biol Chem 278:14379–14386.
   Google Scholar
• Matsubara M, Hasegawa K. 2005. Benidipine, a dihydropyridine- calcium channel blocker, prevents lysophosphatidylcholine-induced injury and reactive oxygen species production in human aortic endothelial cells. Atherosclerosis 178:57–66.
   PubMed Web of Science ®Google Scholar
• Meyer zu HD, Jakobs KH. 2007. Lysophospholipid receptors: Signalling, pharmacology and regulation by lysophospholipid metabolism. Biochim Biophys Acta 1768:923–940.
   Google Scholar
• Miller BA. 2006. The role of TRP channels in oxidative stress-induced cell death. J Membr Biol 209:31–41.
   PubMed Web of Science ®Google Scholar
• Mody N, Parhami F, Sarafian TA, Demer LL. 2001. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 31:509–519.
   PubMed Web of Science ®Google Scholar
• Monet M, Gkika D, Lehen'kyi V, Pourtier A, Vanden Abeele F, Bidaux G, et al. 2009. Lysophospholipids stimulate prostate cancer cell migration via TRPV2 channel activation. Biochim Biophys Acta 1793:528–539.
   PubMed Web of Science ®Google Scholar
• Nilius B, Vriens J, Prenen J, Droogmans G, Voets T. 2004. TRPV4 calcium entry channel: A paradigm for gating diversity. Am J Physiol Cell Physiol 286:C195–C205.
   PubMed Web of Science ®Google Scholar
• Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, et al. 1997. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 17: 680–687.
   PubMed Web of Science ®Google Scholar
• Parhami F, Tintut Y, Beamer WG, Gharavi N, Goodman W, Demer LL. 2001. Atherogenic high-fat diet reduces bone mineralization in mice. J Bone Miner Res 16:182–188.
   PubMed Web of Science ®Google Scholar
• Parthasarathy S, Raghavamenon A, Garelnabi MO, Santanam N. 2010. Oxidized low-density lipoprotein. Methods Mol Biol 610:403–417.
   PubMedGoogle Scholar
• Pedersen SF, Owsianik G, Nilius B. 2005. TRP channels: An overview. Cell Calcium 38:233–252.
   PubMed Web of Science ®Google Scholar
• Phelps CB, Wang RR, Choo SS, Gaudet R. 2010. Differential regulation of TRPV1, TRPV3, and TRPV4 sensitivity through a conserved binding site on the ankyrin repeat domain. J Biol Chem 285:731–740.
   Google Scholar
• Qin N, Neeper MP, Liu Y, Hutchinson TL, Lubin ML, Flores CM. 2008. TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons. J Neurosci 28:6231–6238.
   PubMed Web of Science ®Google Scholar
• Schmitz G, Ruebsaamen K. 2010. Metabolism and atherogenic disease association of lysophosphatidylcholine. Atherosclerosis 208:10–18.
   PubMed Web of Science ®Google Scholar
• So I, Chae MR, Kim SJ, Lee SW. 2005. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces the change of calcium mobilization via TRPC ion channels in cultured human corporal smooth muscle cells. Int J Impot Res 17:475–483.
   Google Scholar
• Song J, Liu K, Yi J, Zhu D, Liu G, Liu B. 2010. Luteolin inhibits lysophosphatidylcholine-induced apoptosis in endothelial cells by a calcium/mitocondrion/caspases-dependent pathway. Planta Med 76:433–438.
   PubMed Web of Science ®Google Scholar
• Steinberg D. 1997. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 272:20963–20966.
   PubMed Web of Science ®Google Scholar
• Takahashi M, Okazaki H, Ogata Y, Takeuchi K, Ikeda U, Shimada K. 2002. Lysophosphatidylcholine induces apoptosis in human endothelial cells through a p38-mitogen-activated protein kinase-dependent mechanism. Atherosclerosis 161:387–394.
   PubMed Web of Science ®Google Scholar
• Uyama O, Yoshimoto Y, Yamamoto Y, Kawai A. 1997. Bone changes and carotid atherosclerosis in postmenopausal women. Stroke 28:1730–1732.
   PubMed Web of Science ®Google Scholar
• Weltzien HU. 1979. Cytolytic and membrane-perturbing properties of lysophosphatidylcholine. Biochim Biophys Acta 559: 259–287.
   PubMed Web of Science ®Google Scholar
• Zhou L, Shi M, Guo Z, Brisbon W, Hoover R, Yang H. 2006. Different cytotoxic injuries induced by lysophosphatidylcholine and 7-ketocholesterol in mouse endothelial cells. Endothelium 13:213–226.
   PubMed Web of Science ®Google Scholar